Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients
Image Credit: Rimma Bondarenko / Shutterstock In a new study, tirzepatide not only outshines semaglutide in cutting diabetes risk but also offers...
